Biological Technologies Office (DARPA)

Last updated

The Biological Technologies Office (BTO) is one of the seven technical offices within DARPA, an agency of the U.S. Department of Defense that is responsible for the development of advanced technology for national security. BTO was created in 2014 by combining some programs from the Defense Sciences Office (DSO) and the Microsystems Technology Office (MTO). [1] The office focuses on basic and applied research in the areas of gene editing, biotechnologies, neurosciences and synthetic biology — from powered exoskeletons for soldiers to brain implants that can control mental disorders. [2] [3]

Contents

DARPA’s embrace of bioscience began in earnest in 2001, when anthrax spores posted to media offices and members of the US Congress brought concerns about bioterrorism to the fore. Then came the wars in Afghanistan and Iraq, which led the agency to invest in fields such as neuroscience, psychology and brain-computer interfaces — all with the intention of helping injured veterans. By 2013, the number of biology-related programmes had grown such that DARPA decided to consolidate them under one roof. [2]

Organization

The first BTO office director in 2014-2015 - Dr. Geoffrey Ling, MD. [4]

The current BTO office director is Dr. Kerri Dugan, who joined joined DARPA as BTO's deputy in August 2019, and was named director in December 2020. [5] Her predecessor was Dr. Bradley Ringeisen, who joined DARPA as BTO’s deputy director in 2015 and was named director in 2019.

Active Programs

The BTO focused on leveraging advances in engineering and information sciences to drive and reshape biotechnology for technological advantage. BTO is responsible for all neurotechnology, human-machine interface, human performance, infectious disease, and synthetic biology programs within the agency. [6]

See also

Related Research Articles

<span class="mw-page-title-main">DARPA</span> Agency of the U.S. Department of Defense responsible for the development of new technologies

The Defense Advanced Research Projects Agency (DARPA) is a research and development agency of the United States Department of Defense responsible for the development of emerging technologies for use by the military.

Neurotechnology encompasses any method or electronic device which interfaces with the nervous system to monitor or modulate neural activity.

Modelling biological systems is a significant task of systems biology and mathematical biology. Computational systems biology aims to develop and use efficient algorithms, data structures, visualization and communication tools with the goal of computer modelling of biological systems. It involves the use of computer simulations of biological systems, including cellular subsystems, to both analyze and visualize the complex connections of these cellular processes.

Brain implants, often referred to as neural implants, are technological devices that connect directly to a biological subject's brain – usually placed on the surface of the brain, or attached to the brain's cortex. A common purpose of modern brain implants and the focus of much current research is establishing a biomedical prosthesis circumventing areas in the brain that have become dysfunctional after a stroke or other head injuries. This includes sensory substitution, e.g., in vision. Other brain implants are used in animal experiments simply to record brain activity for scientific reasons. Some brain implants involve creating interfaces between neural systems and computer chips. This work is part of a wider research field called brain–computer interfaces.

Neuroinformatics is the field that combines informatics and neuroscience. Neuroinformatics is related with neuroscience data and information processing by artificial neural networks. There are three main directions where neuroinformatics has to be applied:

<span class="mw-page-title-main">Harvey Lodish</span> American cell biologist, born 1941

Harvey Franklin Lodish is a molecular and cell biologist, professor at the Massachusetts Institute of Technology (MIT), Founding Member of the Whitehead Institute for Biomedical Research, and lead author of the textbook Molecular Cell Biology. Lodish's research focused on cell surface proteins and other important areas at the interface between molecular cell biology and medicine.

<span class="mw-page-title-main">Donald E. Ingber</span> American cell biologist and bioengineer (born 1956)

Donald E. Ingber is an American cell biologist and bioengineer. He is the founding director of the Wyss Institute for Biologically Inspired Engineering at Harvard University, the Judah Folkman Professor of Vascular Biology at Harvard Medical School and Boston Children's Hospital, and Professor of Bioengineering at the Harvard John A. Paulson School of Engineering and Applied Sciences. He is also a member of the American Institute for Medical and Biological Engineering, the National Academy of Engineering, the National Academy of Medicine, the National Academy of Inventors, and the American Academy of Arts and Sciences.

The White House BRAIN Initiative is a collaborative, public-private research initiative announced by the Obama administration on April 2, 2013, with the goal of supporting the development and application of innovative technologies that can create a dynamic understanding of brain function.

<span class="mw-page-title-main">Geoffrey Ling</span>

Geoffrey S. F. Ling is a medical doctor who retired from the United States Army as a colonel and was the CEO of On Demand Pharmaceuticals. He served as the founding director of the Defense Advanced Research Projects Agency (DARPA) Biological Technologies Office from 2014 until 2016. He was considered to be the "US Army's premier subject matter expert on traumatic brain injury (TBI)", and was for years the only neuro-intensive care specialist in the US military.

Brain technology, or self-learning know-how systems, defines a technology that employs latest findings in neuroscience. [see also neuro implants] The term was first introduced by the Artificial Intelligence Laboratory in Zurich, Switzerland, in the context of the Roboy project. Brain Technology can be employed in robots, know-how management systems and any other application with self-learning capabilities. In particular, Brain Technology applications allow the visualization of the underlying learning architecture often coined as “know-how maps”.

Tapas Kumar Kundu is an Indian molecular biologist, academician and at present the Director of Central Drug Research Institute, a prestigious research institute of Council of Scientific and Industrial Research at Lucknow. He is the head of the Transcription and Disease Laboratory of Jawaharlal Nehru Centre for Advanced Scientific Research. He is known for his studies on the regulation of Gene expression and his contributions in cancer diagnostics and the development of new drug candidates for cancer and AIDS therapeutics. He is an elected fellow of the Indian Academy of Sciences, Indian National Science Academy and the National Academy of Sciences, India and a J. C. Bose National Fellow of the Department of Science and Technology. The Council of Scientific and Industrial Research, the apex agency of the Government of India for scientific research, awarded him the Shanti Swarup Bhatnagar Prize for Science and Technology, one of the highest Indian science awards, in 2005, for his contributions to biological sciences. He is also a recipient of the National Bioscience Award for Career Development of the Department of Biotechnology.

Sanjeev Anant Galande is an Indian cell biologist, epigeneticist, academic, former Chair of Biology and the Dean of Research and Development at the Indian Institute of Science Education and Research, Pune He heads the Laboratory of Chromatin Biology and Epigenetics at Indian Institute of Science Education and Research, Pune. He is the founder of the Centre of Excellence in Epigenetics at IISER Pune and is known for his studies on higher-order chromatin architecture and how it influences spatiotemporal changes in gene expression. He is an elected fellow of the Indian National Science Academy and the Indian Academy of Sciences and a recipient of the National Bioscience Award for Career Development of the Department of Biotechnology. The Council of Scientific and Industrial Research, the apex agency of the Government of India for scientific research, awarded him the Shanti Swarup Bhatnagar Prize for Science and Technology, one of the highest Indian science awards, in 2010, for his contributions to biological sciences.

Kumaravel Somasundaram is an Indian cancer biologist and a professor at the Department of Microbiology and Cell Biology of the Indian Institute of Science. Known for his studies on the therapeutics of Glioblastoma, Somasunderam is an elected fellow of all the three major Indian science academies namely, the National Academy of Sciences, India, the Indian Academy of Sciences and the Indian National Science Academy. The Department of Biotechnology of the Government of India awarded him the National Bioscience Award for Career Development, one of the highest Indian science awards, for his contributions to biosciences in 2006.

Srinivasan Ramachandran is an Indian biologist, bioinformatician and a senior principal scientist at the department of genome analysis of the Institute of Genomics and Integrative Biology. Known for his studies in the field of data analytics, Ramachandran is also an adjunct faculty, senior Principal Scientist and AcSIR Professor at the Faculty of Biological Sciences of the Indian Institute of Technology, Delhi. The Department of Biotechnology of the Government of India awarded him the National Bioscience Award for Career Development, one of the highest Indian science awards, for his contributions to biosciences in 2007.

<span class="mw-page-title-main">Rafael Yuste</span>

Rafael Yuste is a Spanish-American neurobiologist and one of the initiators of the BRAIN Initiative announced in 2013. He is currently a professor at Columbia University.

Horizontal Environmental Genetic Alteration Agents (HEGAAs) are any artificially developed agents that are engineered to edit the genome of eukaryotic species they infect when intentionally dispersed into the environment (outside of contained facilities such as laboratories or hospitals).

<span class="mw-page-title-main">Viviana Gradinaru</span> American neuroscientist and biomedical engineer

Viviana Grădinaru is a Romanian-American neuroscientist who is a Professor of Neuroscience and Biological Engineering at the California Institute of Technology. She develops neurotechnologies including optogenetics CLARITY tissue clearing, and gene delivery vectors. She has been awarded the Presidential Early Career Award for Scientists and Engineers and the National Institutes of Health Director's Pioneer Award. In 2019 she was a finalist for the Blavatnik Awards for Young Scientists. In 2020 she was awarded a Vilcek Prize for Creative Promise in Biomedical Science by the Vilcek Foundation.

<span class="mw-page-title-main">Chet Moritz</span> American neural engineer

Chet T. Moritz is an American neural engineer, neuroscientist, physiologist, and academic researcher. He is a Professor of Electrical and Computer Engineering, and holds joint appointments in the School of Medicine departments of Rehabilitation Medicine, and Physiology & Biophysics at the University of Washington.

The Advanced Research Projects Agency for Health (ARPA-H) is an independent entity within the National Institutes of Health. Its mission is to "make pivotal investments in break-through technologies and broadly applicable platforms, capabilities, resources, and solutions that have the potential to transform important areas of medicine and health for the benefit of all patients and that cannot readily be accomplished through traditional research or commercial activity."

References

  1. ↑ Klabukov, Ilya; Alekhin, Maksim; Nekhina, Anastasiya (2014). "Review of DARPA FY 2015 Research Programs" (PDF). Innovation Practice eJournal. Rochester, NY. 2 (11). doi:10.2139/ssrn.2439081.
  2. 1 2 Reardon, Sara (2015). "The military-bioscience complex". Nature. 522 (7555): 142–144. doi: 10.1038/522142a . PMID   26062493.
  3. ↑ Laursen, Lucas (2014-06-09). "DARPA redesign". Nature Biotechnology. 32 (6): 509. doi: 10.1038/nbt0614-509 .
  4. ↑ Ling, G.; Borrell, B. (2014). "Straight talk with...Geoffrey Ling". Nature Medicine. 20 (6): 570. doi: 10.1038/nm0614-570 . PMID   24901556.
  5. ↑ "Dr. Kerri Dugan, Biological Technologies Office (BTO) Office Director". darpa.mil. Retrieved October 2, 2023.
  6. ↑ "Biological Technologies Office of the DARPA". DARPA BTO.
  7. ↑ "DARPA Enlists Insects to Protect Agricultural Food Supply and Commodity Crops". www.darpa.mil. Retrieved 2019-06-10.
  8. ↑ "Broad Agency Announcement Insect Allies, Biological Technologies Office, HR001117S0002 November 1, 2016". FedBizOpps.gov. 2016.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.